US 11,812,740 · Application 16/615,085 · Granted Nov 14, 2023
US 11,812,740
Method for genetically modifying a vascularised tissue
Estimated expiration
November 15, 2040
14y 48d remaining
- Could not fetch continuity data for application PCTEP2018063581: Resource not found (404)
Earliest effective filing
May 23, 2018
+ 20 years
May 23, 2038
PTA +907d
Nov 15, 2040
No TD
—
Final
Nov 15, 2040
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.
Calculation details
Base term
- Filing date
- November 19, 2019
- Earliest effective filing
- May 23, 2018
- Issue date
- November 14, 2023
- PTA
- +907 days
- Base expiry (before PTA)
- May 23, 2038
May 23, 2018 + 20 years = May 23, 2038 + 907 PTA days = November 15, 2040
- National stage entry of application PCTEP2018063581, filed May 23, 2018
Terminal disclaimers
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
The prosecution record for your AI
Application 16/615,085 · US 11,812,740
You have the date. Your AI can have the file.
PatentReply compiles the prosecution history behind US 11,812,740: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One new public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US11812740Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.